Thursday, April 28, 2011 4:23:33 PM
West Pharma (NYSE:WST)
Intraday Stock Chart
Today : Thursday 28 April 2011
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2011. Summary comparative results were as follows:
($ millions, except per-share data )
Three Months Ended
March 31,
2011
2010
Net Sales
$ 295.4
$ 274.7
Gross Profit
88.0
82.2
Reported Operating Profit
28.8
28.9
Adjusted Operating Profit (1)
30.7
29.5
Reported Diluted EPS
$ 0.56
$ 0.57
Adjusted Diluted EPS(1)
$ 0.60
$ 0.58
(1) See "Restructuring and Other Items" section of the release and "Supplemental Information and Notes to Non-GAAP Financial Measures" in the tables following the text of this release.
First-quarter 2011 sales grew 7.5% from the same period last year, or 7.3% excluding the effects of foreign currency translation. Sales increased 8.5% in Pharmaceutical Packaging Systems and 4.7% in Pharmaceutical Delivery Systems. The overall sales mix improved as a result of growing sales of high-value pharmaceutical packaging components and proprietary devices. Contract manufacturing revenues were flat due to scheduled price reductions that offset other gains, and sales of disposable medical device components declined. The Company's order backlog at the end of the quarter was over 11% higher than the comparable amounts at December 31 and March 31, 2010.
Day trader ideas here.....http://investorshub.advfn.com/boards/board.aspx?board_id=16612
Recent WST News
- West to Participate in Upcoming Investor Conference • PR Newswire (US) • 04/30/2024 10:00:00 AM
- West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend • PR Newswire (US) • 04/25/2024 10:00:00 AM
- West to Host First-Quarter 2024 Conference Call • PR Newswire (US) • 04/11/2024 10:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/01/2024 09:24:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 06:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:35:17 PM
- West to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/28/2024 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 09:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 04:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:50:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:47:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:40:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:29:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:13:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:01:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:44:29 PM
- West Announces Second-Quarter 2024 Dividend • PR Newswire (US) • 02/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:51:00 PM
- West Announces Fourth-Quarter and Full-Year 2023 Results • PR Newswire (US) • 02/15/2024 11:00:00 AM
- West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity • PR Newswire (US) • 02/07/2024 01:00:00 PM
- West to Host Fourth-Quarter and Full-Year 2023 Conference Call • PR Newswire (US) • 02/01/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 10:23:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM